Literature DB >> 12654975

Myasthenia gravis: a higher than expected incidence in the elderly.

J M Aragonès1, I Bolíbar, X Bonfill, E Bufill, A Mummany, F Alonso, I Illa.   

Abstract

This 10-year (1991 to 2000) prospective study of MG in the county of Osona (Barcelona, Spain) reveals an annual incidence rate of 21.27 cases per million inhabitants (95% CI 13.89 to 31.16). Incidence increased from 5.03 x 10(6) in the age group of 0 to 14 years to 14.68 x 10(6) in the age group of 15 to 64 years and to 63.38 x 10(6) in the older population. These results, the highest reported to date, may be explained by the population aging.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654975     DOI: 10.1212/01.wnl.0000050461.05432.c5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Nationwide population-based epidemiological study of myasthenia gravis in taiwan.

Authors:  Chien-Hsu Lai; Hung-Fu Tseng
Journal:  Neuroepidemiology       Date:  2010-06-03       Impact factor: 3.282

Review 2.  Diagnosis and management of autoimmune myasthenia gravis.

Authors:  Corrado Angelini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 3.  Treatment of myasthenia gravis: focus on pyridostigmine.

Authors:  Lorenzo Maggi; Renato Mantegazza
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

4.  Myasthenia gravis: a changing pattern of incidence.

Authors:  I Casetta; E Groppo; R De Gennaro; E Cesnik; L Piccolo; S Volpato; E Granieri
Journal:  J Neurol       Date:  2010-07-11       Impact factor: 4.849

5.  Unusual case of recurrent falls: myasthenia gravis in an elderly patient.

Authors:  Tareef Alaama; Pari Basharat; Michael W Nicolle
Journal:  Can Fam Physician       Date:  2012-11       Impact factor: 3.275

6.  Characteristics of late-onset myasthenia gravis.

Authors:  Saša A Zivković; Paula R Clemens; David Lacomis
Journal:  J Neurol       Date:  2012-04-05       Impact factor: 4.849

Review 7.  Epidemiology of neuroimmunological diseases.

Authors:  Peter Flachenecker
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 8.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

9.  A cohort study on myasthenia gravis patients in China.

Authors:  Wei Wang; Yu-Ping Chen; Zhong-Kui Wang; Dong-Ning Wei; Ling Yin
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

Review 10.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.